Sphingosine kinase-1 activity and expression in human prostate cancer resection specimens

European Journal of Cancer

Volumn 46, Issue 18, 2010, Pages 3417-3424

  Malavaud, Bernard ^a,b,c,d   Pchejetski, Dimitri ^a,d   Mazerolles, Catherine ^c,d   De Paiva, Geisilne Russano ^c   Calvet, Cyril ^a,c   Doumerc, Nicolas ^a,c   Pitson, Stuart ^e   Rischmann, Pascal ^a,b,c,d   Cuvillier, Olivier ^a,b,c,d  

^a INSERM   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c CHU RANGUEIL   (France)

^d INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^e HANSON INSTITUTE   (Australia)

Author keywords

Prostate cancer; Radical prostatectomy; Sphingosine kinase 1; Sphingosine 1 phosphate

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SPHINGOSINE KINASE 1;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RESEARCH; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LAPAROSCOPIC PROSTATECTOMY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATECTOMY; PROTEIN EXPRESSION; SURGICAL TECHNIQUE; TISSUE MICROARRAY; TISSUE SECTION; TREATMENT FAILURE; TUMOR VOLUME;

AGED; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; NEOPLASM PROTEINS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROSTATIC NEOPLASMS;

EID: 78649630419     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.07.053     Document Type: Article

References (45)

1. S. Spiegel, and S. Milstien Sphingosine-1-phosphate: an enigmatic signalling lipid Nat Rev Mol Cell Biol 4 2003 397 407
2. B. Ogretmen, and Y.A. Hannun Biologically active sphingolipids in cancer pathogenesis and treatment Nat Rev Cancer 4 2004 604 616
3. O. Cuvillier, G. Pirianov, and B. Kleuser Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate Nature 381 1996 800 803
4. O. Cuvillier Downregulating sphingosine kinase-1 for cancer therapy Expert Opin Ther Targets 12 2008 1009 1020
5. E. Bonhoure, A. Lauret, and D.J. Barnes Sphingosine kinase-1 is a downstream regulator of imatinib-induced apoptosis in chronic myeloid leukemia cells Leukemia 22 2008 971 979
6. E. Bonhoure, D. Pchejetski, and N. Aouali Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1 Leukemia 20 2006 95 102
7. A. Dayon, L. Brizuela, and C. Martin Sphingosine kinase-1 is central to androgen-regulated prostate cancer growth, survival PLoS One 4 2009 e8048
8. V.E. Nava, O. Cuvillier, and L.C. Edsall Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells Cancer Res 60 2000 4468 4474
9. D. Pchejetski, M. Golzio, and E. Bonhoure Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models Cancer Res 65 2005 11667 11675
10. T.A. Taha, W. Osta, and L. Kozhaya Down-regulation of sphingosine kinase-1 by DNA damage: dependence on proteases and p53 J Biol Chem 279 2004 20546 20554
11. K.J. French, R.S. Schrecengost, and B.D. Lee Discovery and evaluation of inhibitors of human sphingosine kinase Cancer Res 63 2003 5962 5969
12. K.J. French, J.J. Upson, and S.N. Keller Antitumor activity of sphingosine kinase inhibitors J Pharmacol Exp Ther 318 2006 596 603
13. D. Kapitonov, J.C. Allegood, and C. Mitchell Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts Cancer Res 69 2009 6915 6923
14. S.W. Paugh, B.S. Paugh, and M. Rahmani A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia Blood 112 2008 1382 1391
15. D. Pchejetski, N. Doumerc, and M. Golzio Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models Mol Cancer Ther 7 2008 1836 1845
16. P. Xia, J.R. Gamble, and L. Wang An oncogenic role of sphingosine kinase Curr Biol 10 2000 1527 1530
17. K.R. Johnson, K.Y. Johnson, and H.G. Crellin Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue J Histochem Cytochem 53 2005 1159 1166
18. S. Sobue, T. Iwasaki, and C. Sugisaki Quantitative RT-PCR analysis of sphingolipid metabolic enzymes in acute leukemia and myelodysplastic syndromes Leukemia 20 2006 2042 2046
19. M.G. Bayerl, R.D. Bruggeman, and E.J. Conroy Sphingosine kinase 1 protein and mRNA are overexpressed in non-Hodgkin lymphomas and are attractive targets for novel pharmacological interventions Leuk Lymphoma 49 2008 948 954
20. J.R. Van Brocklyn, C.A. Jackson, and D.K. Pearl Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines J Neuropathol Exp Neurol 64 2005 695 705
21. E. Ruckhaberle, A. Rody, and K. Engels Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer Breast Cancer Res Treat 112 2008 41 52
22. J. Guillermet-Guibert, L. Davenne, and D. Pchejetski Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug Mol Cancer Ther 8 2009 809 820
23. T. Kawamori, T. Kaneshiro, and M. Okumura Role for sphingosine kinase 1 in colon carcinogenesis FASEB J 23 2009 405 414
24. J. Li, H.Y. Guan, and L.Y. Gong Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival Clin Cancer Res 14 2008 6996 7003
25. W. Li, C.P. Yu, and J.T. Xia Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients Clin Cancer Res 15 2009 1393 1399
26. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
27. I. Ader, L. Brizuela, P. Bouquerel, B. Malavaud, and O. Cuvillier Sphingosine kinase 1: a new modulator of hypoxia inducible factor 1alpha during hypoxia in human cancer cells Cancer Res 68 2008 8635 8642
28. Y. Akao, Y. Banno, and Y. Nakagawa High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation Biochem Biophys Res Commun 342 2006 1284 1290
29. F.L. Greene, and L.H. Sobin The TNM system: our language for cancer care J Surg Oncol 80 2002 119 120
30. J.E. McNeal, E.A. Redwine, F.S. Freiha, and T.A. Stamey Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread Am J Surg Pathol 12 1988 897 906
31. J.E. McNeal Normal histology of the prostate Am J Surg Pathol 12 1988 619 633
32. D.F. Gleason Histologic grade, clinical stage, and patient age in prostate cancer NCI Monogr 1988 15 18
33. M.E. Chen, D. Johnston, and A.O. Reyes A streamlined three-dimensional volume estimation method accurately classifies prostate tumors by volume Am J Surg Pathol 27 2003 1291 1301
34. A. Heidenreich, G. Aus, and M. Bolla EAU guidelines on prostate cancer Eur Urol 53 2008 68 80
35. S.M. Pitson, P.A. Moretti, and J.R. Zebol Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation EMBO J 22 2003 5491 5500
36. M.A. Rubin, M. Zhou, and S.M. Dhanasekaran Alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer JAMA 287 2002 1662 1670
37. Y.A. Hannun, and L.M. Obeid Principles of bioactive lipid signalling: lessons from sphingolipids Nat Rev Mol Cell Biol 9 2008 139 150
38. H. Liu, R.E. Toman, and S.K. Goparaju Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis J Biol Chem 278 2003 40330 40336
39. M. Maceyka, H. Sankala, and N.C. Hait SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism J Biol Chem 280 2005 37118 37129
40. R. Sutphen, Y. Xu, and G.D. Wilbanks Lysophospholipids are potential biomarkers of ovarian cancer Cancer Epidemiol Biomarkers Prev 13 2004 1185 1191
41. P. Vaupel, and A. Mayer Hypoxia in cancer: significance and impact on clinical outcome Cancer Metastasis Rev 26 2007 225 239
42. A. Turaka, M.K. Buyyounouski, A.L. Hanlon, E.M. Horwitz, R.E. Greenberg, and B. Movsas Correlation of hypoxic prostate/muscle pO2 (P/M pO2) ratio and biochemical failure in patients with localized prostate cancer: long-term results J Clin Oncol 27 2009 #5136
43. I. Ader, B. Malavaud, and O. Cuvillier When the sphingosine kinase 1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapy Cancer Res 69 2009 3723 3726
44. M. Kozak Some thoughts about translational regulation: forward and backward glances J Cell Biochem 102 2007 280 290
45. G.W. Sledge Jr. What is targeted therapy? J Clin Oncol 23 2005 1614 1615